HCW Biologics is trading 5.9% up now at $2.86 as broader risk-on sentiment supports higher-beta growth stocks.
- No new company-specific announcement dated August 26 or August 27, 2026, was identified.
- The Nasdaq was up 1.10%, while investors remained encouraged by Nvidia’s outlook and gains across technology sectors.
- The move therefore appears globally driven rather than linked to a fresh company catalyst.